Edgewise Therapeutics Inc (EWTX) Event Aug. 04, 2022, 00:00 UTC (76% Positive) Edgewise Therapeutics, Inc. (EWTX) Reports 44% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 11 a.m. 🏢 Edgewise Therapeutics Inc (EWTX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-17.17M $-30.73M $13.56M +44.13% 📉 Total Assets $285.23M $257.40M $27.83M +10.81% 📈 Total Liabilities $10.85M $11.04M $-194.00K -1.76% ↘️ Stockholders' Equity $246.35M $-107.69M $354.04M +328.77% 📈 Operating Income/Loss $-17.32M $-31.32M $14.00M +44.70% 📉 R&D Expense $13.22M $23.53M $-10.30M -43.80% 📈 Earningspersharebasic $-0.67 $-0.62 $-0.05 -8.06% 📉 Earningspersharediluted $-0.67 $-0.62 $-0.05 -8.06% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Edgewise Therapeutics Inc (EWTX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document